Fluoride‐Oxalate and Lithium Heparin Anticoagulant Tubes Are Reliable Alternatives to EDTA for HbA1c Measurement
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/7743935 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 20.08.2026. Verfasst von Lamia Abdellaoui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia, pasteur.tn. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Edetic Acid, Anticoagulants, Heparin. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The dual role of HbA1c in diagnosing and monitoring diabetes mellitus has driven a continuous increase in routine testing requests. To optimize laboratory workflows and avoid dedicated EDTA blood draws, this study is aimed at determining whether fluoride‐oxalate and lithium heparin anticoagulant tubes could serve as reliable alternatives to EDTA tubes for HbA1c measurement on the COBAS INTEGRA 400 plus analyzer.
Methods
Over 2 months at the Pasteur Institute of Tunis, paired blood samples from patients undergoing routine HbA1c testing were analyzed. Standard K3‐EDTA tubes were compared with either lithium heparin or fluoride‐oxalate tubes using a turbidimetric inhibition immunoassay on a COBAS INTEGRA 400 plus analyzer. The study relied exclusively on residual clinical material without imposing specific preanalytical restrictions.
Results
The study population comprised 277 patients, divided into Group 1 (K3‐EDTA vs. fluoride‐oxalate, n = 200) and Group 2 (K3‐EDTA vs. lithium heparin, n = 77). HbA1c results from both alternative tubes showed strong correlation with K3‐EDTA ( r = 0.99, p < 0.0001), with no significant overall differences. Passing–Bablok regression revealed no constant or proportional bias for lithium heparin, whereas a systematic bias was observed for fluoride‐oxalate. Bland–Altman analysis of log‐transformed data indicated no significant mean bias for either fluoride‐oxalate (−0.15%; 95% LoA [−2.76% to +2.53%]) or lithium heparin (−0.04%; 95% LoA [−2.77% to +2.76%]), although a slight proportional bias was detected in both. Finally, HbA1c measurements in both tube types exhibited high diagnostic performance at clinical cutoffs ( p < 0.0001).
Conclusions
Fluoride‐oxalate and lithium heparin anticoagulant tubes provide reliable alternatives to standard K3‐EDTA tubes for HbA1c measurement, with no clinically meaningful differences observed. However, we emphasize that these results are strictly validated for the Roche COBAS immunoassay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia, pasteur.tn.
ORCID-Profile: Lamia Abdellaoui, Asma Krir, Manel Soltani, Mehdi Mrad
Zitieren
APA
Abdellaoui, L., Krir, A., Soltani, M., Trabelsi, A., Mrad, M., & Bahlous, A. (2026). Fluoride‐Oxalate and Lithium Heparin Anticoagulant Tubes Are Reliable Alternatives to EDTA for HbA1c Measurement. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/7743935
Vancouver
Abdellaoui L, Krir A, Soltani M, Trabelsi A, Mrad M, Bahlous A. Fluoride‐Oxalate and Lithium Heparin Anticoagulant Tubes Are Reliable Alternatives to EDTA for HbA1c Measurement. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/7743935
BibTeX
@article{Abdellaoui2026,
author = {Abdellaoui, Lamia and Krir, Asma and Soltani, Manel and Trabelsi, Aouatef and Mrad, Mehdi and Bahlous, Afef},
title = {Fluoride‐Oxalate and Lithium Heparin Anticoagulant Tubes Are Reliable Alternatives to EDTA for HbA1c Measurement},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/7743935}
}
EUVIMED